<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-cyclophosphamide.xml</id>
  <title>Recalls Watch: Cyclophosphamide</title>
  <link rel="self" href="https://recalls.watch/feed/substance-cyclophosphamide.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-08-12T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99437/</id>
    <title>Sunny Pharmtech Inc.: Cyclophosphamide for Injection and 1 more</title>
    <link href="https://recalls.watch/recall/fda/99437/"/>
    <updated>2026-08-12T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of Particulate Matter; identified as stainless steel</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/n-sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injectio/</id>
    <title>Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter</title>
    <link href="https://recalls.watch/recall/fda/n-sunny-pharmtech-inc-issues-voluntary-nationwide-recall-cyclophosphamide-injectio/"/>
    <updated>2026-07-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of particulate matter identified as steel</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/97549/</id>
    <title>Sandoz Inc: Cyclophosphamide Injection 500 mg/5 mL</title>
    <link href="https://recalls.watch/recall/fda/97549/"/>
    <updated>2025-09-24T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: cGMP deviations: Temperature excursion during transportation.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/94348/</id>
    <title>X-Gen Pharmaceuticals Inc.: Cyclophosphamide for Injection and 1 more</title>
    <link href="https://www.accessdata.fda.gov/scripts/ires/index.cfm?Event=94348"/>
    <updated>2024-04-10T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Labeling: Incorrect or missing Package Insert: There is an error on the Package Insert (PI), section 2.3, Preparation, Handling, and Administration. The concentration of the reconstituted product is listed as '20 mg per vial.' This information should read: '20 mg per mL'.</summary>
  </entry>
</feed>
